Decline in Number of Clinical Trials for Alzheimer’s Disease (BBC News / Alzheimer’s Research & Therapy)

Summary

More than 99% of drug trials for Alzheimer’s Disease during the past decade have failed. An article in the Alzheimer’s Research & Therapy journal discusses an issue which was perhaps the key focus of the Global Dementia Legacy Event. Only one new medicine has been approved since 2004; 99.6% of drug trials aimed at preventing, curing or improving the symptoms of Alzheimer’s Disease between 2002 and 2012 either failed or were discontinued.

Full Text Link

Reference

Briggs, H. (2014). Decline in trials for Alzheimer’s disease. London: BBC Health News, July 3^rd 2014.

This relates to:

Full Text Link

Reference

Cummings, JL. Morstorf, T. [and] Zhong, K. (2014). Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimer’s Research & Therapy, July 3^rd 2014. 6: 37.

[A version of this item features in Dementia: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 12, July 2014].